“Radiopharmaceuticals” — FilingIndex Search

Filter

15 of 3,901

Sort

GEHCGE HealthCare Technologies Inc.⚡

Healthcare · Medical Devices

$29.65B-1.6%

P/E 13.8·P/S 1.4·Mgn 10.4%·ROE 20.1%·FCF 5.1%

F 5

BWXTBWX Technologies, Inc.

Industrials · Machinery

$17.72B+2.9%

P/E 51.4·P/S 5.2·Mgn 10.2%·ROE 26.7%·FCF 1.7%

F 5

LNTHLantheus Holdings, Inc.

Healthcare · Diagnostics & Tools

$6.80B+1.2%

P/E 24.4·P/S 4.4·Mgn 18.0%·ROE 21.4%·FCF —

F 4

Red 8-K

RDNTRadNet, Inc.

Healthcare · Healthcare Services

$4.46B+4.0%

P/E 202.2·P/S 2.1·Mgn 1.0%·ROE -1.7%·FCF —

—

MIRMirion Technologies, Inc.

Healthcare · Medical Devices

$4.05B+2.7%

P/E 155.8·P/S 4.1·Mgn 2.7%·ROE 1.5%·FCF 2.6%

F 6

Red 8-K

CRNXCrinetics Pharmaceuticals, Inc.

Healthcare · Pharmaceuticals

$3.63B+1.3%

P/E —·P/S 201.1·Mgn -2747.2%·ROE -46.9%·FCF -10.6%

F 2

Red 8-K

VRDNViridian Therapeutics, Inc.DE

Healthcare · Pharmaceuticals

$1.81B-2.2%

P/E —·P/S 25.5·Mgn -483.6%·ROE -47.4%·FCF -15.3%

—

13D

AKTSAktis Oncology, Inc.

Healthcare · Pharmaceuticals

$1.21B+7.0%

P/E —·P/S 41.2·Mgn -524.5%·ROE —·FCF —

—

Red 8-K

JANXJanux Therapeutics, Inc.

Healthcare · Pharmaceuticals

$827M+0.2%

P/E —·P/S 60.2·Mgn -833.6%·ROE -11.9%·FCF -10.1%

—

Red 8-K

ASPIASP Isotopes Inc.

Materials · Chemicals

$825M0.0%

P/E —·P/S 30.6·Mgn -588.6%·ROE -78.3%·FCF -5.8%

F 4

Dilut.

MNPRMonopar Therapeutics

Healthcare · Pharmaceuticals

$400M-2.1%

P/E —·P/S —·Mgn —·ROE -10.0%·FCF —

—

CATXPerspective Therapeutics, Inc.

Healthcare · Pharmaceuticals

$336M-3.9%

P/E —·P/S 231.4·Mgn -5596.7%·ROE -28.0%·FCF —

—

BCYCBICYCLE THERAPEUTICS PLC

Healthcare · Pharmaceuticals

$283M+2.2%

P/E —·P/S 10.0·Mgn -884.5%·ROE -35.9%·FCF -89.1%

—

MOLNMOLECULAR PARTNERS AG

Healthcare · Biotechnology

$154M-2.3%

P/E 1.1·P/S 0.7·Mgn 62.2%·ROE -76.7%·FCF -41.6%

P/E —·P/S 37.4·Mgn -496.8%·ROE -19.8%·FCF -12.3%

—

Filings · filterAll 10-K 10-Q 8-K S-1 DEF 14A SC 13D

Filings

40 shown

BRLSWBorealis Foods Inc.

10-Q

Quarterly report — three-month financials and management discussion.

Jun 30, 2026·18h ago

PRPHProPhase Labs, Inc.

10-Q

Quarterly report — three-month financials and management discussion.

Companies above the $50M market cap · $1 pricefloor; SPAC/shells hidden by default. Fundamentals & prices via Polygon · signals from SEC EDGAR — verify on SEC.gov. Filings current to Jun 30 · prices to Jun 30.